Page 160 - Williams Hematology ( PDFDrive )
P. 160

134  Part III:  Epochal Hematology                                 Chapter 9:  Hematology in Older Persons            135




                  noted with age. 200–203  To date, a longitudinal data set describing altera-  correlation for adverse outcomes was stronger with D-dimer than
                  tions in platelet number with advancing age has not been produced nor   IL-6.  In this, and other studies, 234–236  D-dimer and other markers of
                                                                            233
                  are there conclusive studies describing age-associated changes in plate-  activated coagulation were associated with limitation in a wide variety
                  let function.                                         of functional domains, including independent activities of daily living
                                                                        (IADL), lower-extremity function, and performance on cognitive test-
                  AGING AND COAGULATION                                 ing. The age-associated changes in coagulation markers occur earlier
                  Coagulation Factors and Aging                         than other aging biomarkers, and hence it has been argued that they
                  A number of proteins critical to clot formation and fibrinolysis change in   could be early predictors of those elderly at increased risk for functional
                                                                              237
                  characteristic ways with advancing age. 204–206  Plasma concentrations of   decline.
                  factor VII coagulant activity and antigen, 204–208  and factor VIIIC, 191,206,209    This age-associated prominence of coagulation factors has also
                  as well as von Willebrand factor, 191,209  fibrinogen, 191,206,208,210  fibrinopep-  been reproduced in animals. For example, when stress associated with
                  tide A, 191,206,207  and tissue plasminogen activator antigen 191,211–213  increase   physical restraint was compared in aged versus young C57BL/6J mice,
                  with age. In healthy centenarians, levels of activated factor VII, activation   significantly increased expression of PAI-1 mRNA was noted in almost
                                                                                            238
                  peptides of prothrombin, factors IX and X, and thrombin–antithrombin   all the tissues in older mice.  Similar results were seen for expression of
                                                                                                238
                  complex concentration were increased, which are signs of higher-than-  tissue factor mRNA in aged mice.  In both these experimental models
                  expected coagulation enzyme activity.  Age-associated increases in   an increase in microthrombi was noted with clots distributed through
                                              206
                  levels of protein C occur in both sexes. Aging is also associated with   multiple organ systems in the older mice.
                  increasing levels of free protein S.  In contrast, antithrombin tends to   In humans, both the presence of depression and/or psychological
                                          204
                                                                                                            239–241
                  decrease with age in males and increases with age in females following   stress  are  associated  with  increased  coagulation    and  decreased
                                                                                       242
                  menopause.  Higher D-dimer and plasmin–antiplasmin complexes   fibrinolytic  activity.  In elderly subjects without cardiovascular dis-
                          214
                  indicate an accompanying increase in fibrinolytic activity. 206,215  In con-  ease, physical exhaustion, a characteristic frequently used to distinguish
                  trast, plasma tissue-plasminogen activator inhibitor levels increase with   frail from nonfrail individuals, was associated with significant increases
                  increasing age, as do levels of thrombin-activatable fibrinolysis inhibitor   in both inflammatory and coagulation factors as assessed by fibrinogen,
                                                                                                      239
                  in women  and its proenzyme form, procarboxypeptidase U, in both   C-reactive protein, and white cell levels.  Frail and prefrail subjects
                         216
                  sexes.  These latter findings are suggestive of a possible age-dependent   from the Cardiovascular Health Study had significantly higher levels of
                      217
                  compromise in fibrinolytic activity.  Thus, procoagulant and, in some   fibrinogen, factor VIII, and D-dimer levels as compared to the nonfrail
                                           218
                  studies, fibrinolytic activities appear to be increased in older subjects by   group. The association with frailty persisted even after adjusting for the
                                                                                                           243
                  both in vitro 206,219,220  and in vivo studies, 190,221  but the changes in fibrino-  presence of cardiovascular disease and diabetes.  Frailty is also associ-
                  lytic activity are inconsistent. Older patients may show an exaggerated   ated with increased risk of venous thromboembolism when compared
                  anticoagulant response to warfarin. 222               to nonfrail individuals of the same age, especially in association with
                                                                        increased factor VIII levels. 244
                  Aging as a Prothrombotic State
                  Activation of the coagulation  system and increase in procoagulant
                  markers are associated with the pathogenesis of atherosclerosis. 223,224    AGING AND IMMUNITY
                  However, procoagulant markers, most notably D-dimer,  fibrinogen,   Whether related to primary processes of aging or not, the thymus gland
                                                           225
                  and factor VIII,  also increase with advancing age, and may, in fact,   undergoes a very characteristic pattern of involution beginning well in
                             226
                  correlate better with aging than with cardiovascular disease. 223,224  In a   advance of other phenotypic changes attributed to aging (see Figs. 9–1
                  study examining 1729 participants age 70 years and older in the Estab-  and 9–2; Chap. 6).  Among the consequences are a decreased gener-
                                                                                      245
                  lished Populations for the Epidemiological Study of the Elderly (EPESE)   ation of naïve T cells.  Despite this, the total lymphocyte count does
                                                                                        246
                  cohort, increasing age was associated with high D-dimer levels. For   not decline greatly because peripheral T cells are capable of expanding
                  example, 23 percent of the participants age 90 to 99 years had high     to fill the T-cell niche in the absence of generation of new T cells. How-
                  D-dimer levels (>600 mcg/L) compared to 13 percent in the 80- to   ever, when they do so, the repertoire for antigen recognition becomes
                  89-year-old age group and 7 percent in the 70- to 79-year-old age   less comprehensive. Thymic involution may result from the aging T-cell
                                                                                         247
                  group.  Investigators measured fibrinogen concentrations in healthy   progenitor population,  from the defects in rearrangement of T-cell
                      215
                  subjects ages 19 to 96 years and found levels to be significantly higher   receptor β genes, 248,249  from loss of self-peptide expressing thymic epi-
                                                                                                                      251
                                                                              250
                  in participants older than age 60 years when compared to younger sub-  thelium,  and/or from the loss of thymic trophic cytokines.  Thy-
                  jects.  Healthy individuals across the life span had fibrinogen levels   mic epithelial cells produce a variety of colony-stimulating factors and
                     227
                  increased by 25 mg/dL per decade of life, and levels as high as 320 mg/  hematopoietic cytokines, such as IL-1, IL-3, IL-6, IL-7, transforming
                  dL were found in more than 80 percent of people older than 65 years   growth factor-β, oncostatin M, and leukemia inhibitory factor, 252–254
                  of age.  Other markers of activated coagulation, such as plasmino-  which influence the complex process of T-cell production. It is pro-
                       228
                  gen activating inhibitor-I (PAI-1) and factor VIII also increased with   posed that thymic atrophy and decreased thymopoiesis is an active pro-
                  age. 209,229,230  Thus, it is now apparent that aging is associated with markers   cess and mediated by the upregulation of thymosuppressive cytokines
                  of activated coagulation. In this context, it is notable that the incidence   (leukemia inhibitory factor, IL-6, and oncostatin M), which results in
                  of venous thrombosis and pulmonary emboli increases dramatically in   the  altered  peripheral lymphatic  tissue  T-lymphocyte  function  with
                  geriatric populations. 231,232  Bleeding complications from anticoagulation   aging. 255
                  therapy are also increased in older patients. No interventional study has   There  is  a  notable  shift  in  the  overall  blood  T-cell  population
                                                                                                               256
                  identified an at-risk population of normal-age subjects without prior   toward lymphocytes with memory T-cell markers,  and many of
                                                                                                                   257
                  thrombosis in whom prophylactic anticoagulation is of value.  these are thought to have attained replicative senescence.  With the
                                                                        decreasing numbers of naïve T cells in the peripheral lymphatic tissue
                  Coagulation and Functional Decline                    and increasing memory T cells reaching  senescence, elderly persons
                  In the EPESE study, increases in D-dimer and interleukin (IL)-6 were   have difficulties responding to old and new antigens and demonstrate
                                                          215
                  related to  increases in  both morbidity  and  mortality.   In  fact,  the   impaired reactions to vaccinations. The decreased efficacy of vaccines
          Kaushansky_chapter 09_p0129-0142.indd   135                                                                   17/09/15   6:16 pm
   155   156   157   158   159   160   161   162   163   164   165